Case studies
Selected work, anonymized.
Engagements we're proud of, with the names removed. Happy to walk through any of these in person.
Top-10 global pharma
Oncology launch forecast for a first-in-class asset
A pre-launch oncology asset needed a defensible patient-based forecast spanning four indications and three competitive scenarios.
$1.4B
peak-year revenue forecast accepted by finance
Mid-cap specialty pharma
Unified brand performance platform across five brands
Brand teams were stitching together TRx, claims, and field data manually each month, losing days to reconciliation.
−62%
reduction in monthly reporting cycle time
Top-20 pharma, immunology
Field force resize and realignment for a maturing brand
A maturing immunology brand was overspending on declining segments and under-covering emerging high-value HCPs.
+18%
lift in high-value HCP reach within 2 quarters